Group One Trading’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8K Buy
3,653
+3,043
+499% +$11.5K ﹤0.01% 6261
2026
Q1
$2.35K Sell
610
-1,464
-71% -$5.76K ﹤0.01% 7003
2025
Q4
$8.15K Buy
+2,074
New +$9.17K ﹤0.01% 6926
2025
Q1
Sell
-167
Closed -$780 8444
2024
Q4
$947 Sell
167
-79
-32% -$509 ﹤0.01% 6902
2024
Q3
$1.44K Buy
+246
New +$1.79K ﹤0.01% 6223
2024
Q1
Sell
-135
Closed -$1.14K 8045
2023
Q4
$1.14K Buy
+135
New +$979 ﹤0.01% 6967
2022
Q1
Sell
-4,736
Closed -$21.1K 8794
2021
Q4
$13K Buy
+4,736
New +$16.2K ﹤0.01% 7241
2020
Q2
Sell
-4,087
Closed -$47.5K 6229
2020
Q1
$37K Sell
4,087
-5,000
-55% -$57.4K ﹤0.01% 3910
2019
Q4
$127K Buy
+9,087
New +$132K ﹤0.01% 3483
2019
Q2
Sell
-100
Closed -$2.29K 5433
2019
Q1
$2K Buy
+100
New +$1.3K ﹤0.01% 4609
2018
Q4
Sell
-806
Closed -$10.3K 5463
2018
Q3
$15K Sell
806
-100
-11% -$1.92K ﹤0.01% 4503
2018
Q2
$18K Sell
906
-7,492
-89% -$148K ﹤0.01% 4418
2018
Q1
$158K Buy
+8,398
New +$182K ﹤0.01% 2951
2017
Q4
Sell
-9,647
Closed -$165K 5271
2017
Q3
$199K Buy
9,647
+8,342
+639% +$94.1K ﹤0.01% 2761
2017
Q2
$12K Buy
+1,305
New +$13.1K ﹤0.01% 4144

Other funds holding VYGR

Group One Trading's VYGR Position: Q2 2026 in Review

Group One Trading increased its Voyager Therapeutics (VYGR) stake by 499% in Q2 2026, buying an estimated $11.5K and bringing the position to 3,653 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6261.

Group One Trading first reported a position in VYGR in Q2 2017 and has held it in 15 quarters since. The position peaked at $199K in Q3 2017. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Group One Trading held 3,653 shares of Voyager Therapeutics worth $12.8K as of Q2 2026.
  • Group One Trading bought 3,043 Voyager Therapeutics shares in Q2 2026, an estimated $11.5K.
  • Voyager Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6261 holding.
  • Group One Trading first reported a position in Voyager Therapeutics in Q2 2017 and has held it in 15 quarters since.
  • Group One Trading's Voyager Therapeutics position peaked at $199K in Q3 2017.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.